NL-OMON27198
已完成
不适用
A randomized, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexate.
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Rheumatoid arthritis (RA)
- 发起方
- Millennium Pharmaceuticals Inc.
- 入组人数
- 186
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
/A
研究者
入排标准
入选标准
- •1\. Age 18\-70;
- •2\. Meeting ACR criteria for RA;
排除标准
- •1\. Use of any other DMARDS than MTX concomitantly or within one month prior to enrollment (in case of leflunomide, 3 months prior to enrollment or washout with cholestyramine);
- •2\. Currently being treated with TNF\-antagonists or other biologicals (washout period 8 weeks);
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
A study investigating the efficacy and safety of 2 doses of NuSepin® intravenous infusion in adult subjects with Covid-19 pneumoniaAdult subjects with Covid-19 pneumoniaTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-003107-34-ROShaperon Inc60
进行中（未招募）
1 期
A randomized, double blind, placebo controlled, phase II, multi-centre pilot study to investigate the effects of vitamin D2 or D3 supplementation on metabolic parameters in people at risk of type 2 diabetes. - Vitamin D Supplementation in People at Risk of Type 2 Diabetes V1.3EUCTR2009-011264-11-GBQueen Mary University of London340
进行中（未招募）
不适用
A randomized, double blind, placebo controlled, phase II, dose-titration trial to explore the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatremia.Cirrhotic subjects with ascites and hypo- or normonatraemiaMedDRA version: 9.1Level: LLTClassification code 10009213Term: Cirrhosis of liverMedDRA version: 9.1Level: LLTClassification code 10003445Term: AscitesMedDRA version: 9.1Level: LLTClassification code 10021038Term: HyponatremiaEUCTR2007-001711-31-DEMovetis NV12
进行中（未招募）
不适用
A randomized, double blind, placebo controlled, phase II, dose-titration trial to explore the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatraemia.Cirrhotic subjects with ascites and hyponatremiaMedDRA version: 9.1Level: LLTClassification code 10009213Term: Cirrhosis of liverMedDRA version: 9.1Level: LLTClassification code 10003445Term: AscitesMedDRA version: 9.1Level: LLTClassification code 10021038Term: HyponatremiaEUCTR2007-001711-31-BEMovetis NV18
已完成
不适用
Phase I study to assess the pharmacokinetics and pharmacodynamics of macitentan in Korean healthy male subjectsDiseases of the circulatory systemKCT0000326Actelion Pharmaceuticals Korea30